TY - JOUR T1 - Review: antidepressants increase remission and clinical improvement in bulimia nervosa JF - Evidence Based Medicine JO - Evid Based Med SP - 86 LP - 86 DO - 10.1136/ebm.7.3.86 VL - 7 IS - 3 A2 - , Y1 - 2002/05/01 UR - http://ebm.bmj.com/content/7/3/86.abstract N2 - (2001) Cochrane Database Syst Rev. Bacaltchuk J, Hay P. . Antidepressants versus placebo for people with bulimia nervosa.. ;(4):CD003931 (latest version 19 Aug 2001).. 
 
 QUESTION: In patients with bulimia nervosa (BN), are antidepressants effective for increasing remission and clinical improvement? Studies were identified by searching Medline; EMBASE/Excerpta Medica; LILACS; PsycLIT; SCISEARCH; the Cochrane Depression, Anxiety, and Neurosis Group Database of Trials; the Cochrane Controlled Trials Register; Clinical Evidence; and reference lists. The International Journal of Eating Disorders was also hand searched, and authors and pharmaceutical companies were contacted. Studies were selected if they were randomised controlled trials (RCTs) that compared any antidepressant with placebo for ≥ 4 weeks in patients with BN. RCTs were excluded if patients had binge-eating or purging-type anorexia nervosa or binge-eating disorder. 2 reviewers assessed the quality of RCTs and extracted data on patients, study characteristics, drug regimens, and outcomes (including remission [100% reduction in binge or purge episodes], clinical improvement [≥ 50% reduction in binge or purge episodes], and drop outs). 16 RCTs (1300 patients) met the selection criteria. Any antidepressant was better than placebo for increasing remission at a mean follow … ER -